Immunogenicity of a Third Dose of Either the Moderna COVID-19 Vaccine or Pfizer-BioNTech COVID-19 Vaccine in Kidney Transplant Recipients Who Failed to Respond After Two Previous Doses
Latest Information Update: 24 Oct 2024
At a glance
- Drugs Elasomeran (Primary) ; Tozinameran (Primary)
- Indications COVID 2019 infections
- Focus Therapeutic Use
- Acronyms CPAT
- 24 Mar 2023 Results published in the American Journal of Transplantation
- 20 Mar 2023 Status changed from active, no longer recruiting to completed.
- 04 Oct 2021 Planned primary completion date changed from 1 Oct 2021 to 1 Nov 2021.